Normal Saline for Parenteral Use Sales

Normal Saline for Parenteral Use Sales Market Outlook

The global market for normal saline for parenteral use is anticipated to reach approximately USD 1.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 5.2% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic diseases that necessitate intravenous therapies, a rising geriatric population, and a surge in surgical procedures that require fluid management. Additionally, advancements in healthcare infrastructure and a push towards enhanced patient care practices are also expected to drive demand for normal saline solutions. The robust increase in outpatient treatments and home healthcare services further complements this growth trajectory. As healthcare providers explore more effective ways to deliver treatments and manage patient care, the normal saline market is set to expand significantly in the coming years.

Growth Factor of the Market

Several key factors are propelling the growth of the normal saline for parenteral use market. Firstly, the rise in the incidence of conditions such as dehydration, electrolyte imbalances, and surgical interventions has led to a higher requirement for intravenous fluids, including normal saline. Furthermore, as healthcare systems evolve and adopt more patient-centric models, there is an increasing trend towards the use of normal saline in home care settings, enabling patients to receive care in the comfort of their homes. The development of safer and more efficient delivery systems for normal saline also supports growth, as they can improve patient outcomes and reduce the risk of infections. In addition, the expansion of pharmacies and healthcare facilities that offer parenteral solutions is enhancing accessibility, thus driving demand. Lastly, increased awareness among healthcare professionals regarding the importance of fluid balance in patient care is further fueling the market's growth.

Key Highlights of the Market

• The global normal saline for parenteral use market is projected to grow at a CAGR of 5.2% from 2025 to 2035.
• Rising chronic diseases and the geriatric population are significant drivers of market growth.
• The home healthcare segment is becoming increasingly vital, reflecting changing care models.
• Technological advancements in intravenous therapy are enhancing the safety and efficacy of saline delivery.
• The competitive landscape includes a mix of large multinational corporations and specialized local manufacturers.

By Product Type

Plastic Bottles:

Plastic bottles are the most widely used packaging method for normal saline solutions, offering a lightweight and shatterproof alternative to glass. This product type is preferred in hospitals and clinics due to its ease of use and reduced risk of breakage, which can lead to contamination and waste. The flexibility of plastic allows for various sizes and shapes, making it suitable for different medical applications. Moreover, the availability of sterile and pre-filled options increases their appeal, ensuring that healthcare providers can access ready-to-use solutions without additional preparation. The plastic bottle segment is expected to maintain a significant market share, driven by a growing demand for convenient and safe IV therapies.

Glass Bottles:

Glass bottles have traditionally been used for the packaging of normal saline due to their inert properties and ability to maintain the sterility of the solution. They are preferred in some healthcare settings where longer shelf life and chemical stability are paramount. Glass bottles do not interact with the saline, ensuring that the integrity of the solution remains intact. However, the fragility of glass may limit their use in certain environments. Despite this, the glass bottle segment remains relevant, especially in specialty pharmacies and hospitals that prioritize the quality of IV solutions. The market for glass bottles is expected to remain stable, albeit with moderate growth compared to plastic alternatives.

IV Bags:

IV bags are gaining popularity as a convenient packaging solution for normal saline due to their flexibility and ease of administration. They are lightweight and can be manufactured in various sizes, making them suitable for both adult and pediatric patients. The use of IV bags minimizes the risk of contamination, as they are designed for single use and are often equipped with integrated delivery systems. The trend towards using IV bags over traditional bottles is driving their market growth, particularly in hospitals and outpatient care settings where swift and efficient fluid administration is essential. Furthermore, the innovation in IV bag technology, such as anti-air embolism designs and improved compatibility with infusion pumps, is expected to enhance their market presence in the coming years.

IV Bottles:

IV bottles serve as another critical component in the normal saline market, providing a reliable means to deliver intravenous therapy. These bottles are typically made from recyclable materials and can be designed to be lightweight, making them easier for healthcare providers to handle. IV bottles are particularly favored in intensive care and surgical settings, where rapid access to saline is crucial. Their compatibility with various types of infusion systems and equipment also makes them highly versatile. As hospitals continue to focus on improving patient outcomes and minimizing complications, the demand for IV bottles is projected to grow steadily, supported by the advancements in the quality of these products.

Ampoules:

Ampoules are sealed glass or plastic containers that offer an alternative method for packaging normal saline. They are typically used for specific applications where sterility and accuracy in dosing are essential. The primary advantage of ampoules lies in their ability to provide single doses of saline, thus minimizing waste and reducing the risk of contamination compared to multi-dose containers. This segment is particularly relevant in emergency settings and for specialty pharmaceutical applications. While the ampoule market is smaller compared to other packaging types for normal saline, it is characterized by its specialized use cases and is expected to grow modestly as demand for precision medicine and personalized treatments increases.

By Application

Hospitals:

Hospitals represent the largest application segment for normal saline due to their comprehensive utilization in various medical procedures, including surgeries, emergency care, and routine hydration. Normal saline is a staple in IV therapy, serving to restore fluid balance, administer medications, and provide nutritional support. Hospitals are equipped with sophisticated infrastructures that facilitate the safe and efficient use of normal saline in diverse clinical settings. The demand in this segment is consistently high, driven by the continuous influx of patients requiring medical attention and the growing complexity of treatments being provided. The expanding range of surgical procedures and advancements in medical technology further enhance the reliance on normal saline within hospital environments.

Clinics:

Clinics play a vital role in the administration of normal saline for outpatient care, including routine hydration, minor surgical procedures, and treatment of acute conditions. The growing trend towards outpatient services has resulted in increased demand for normal saline solutions in clinical settings. As healthcare shifts towards preventive care and quick treatment options, clinics are becoming essential providers of IV therapy. The accessibility and convenience of receiving treatments at clinics instead of hospitals empower patients and contribute to overall healthcare efficiency. Additionally, the rise of telemedicine and remote patient monitoring further underscores the importance of clinics in facilitating the use of normal saline for parenteral use.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are increasingly utilizing normal saline to support outpatient surgical procedures. These centers are designed to provide same-day discharge for patients, making efficient fluid management critical. Normal saline is used for hydration, medication delivery, and to maintain electrolyte balance during and after surgeries. The growing preference for minimally invasive procedures performed in ASCs is driving demand for normal saline solutions, as patients require precise fluid management to ensure optimal recovery. The transition towards outpatient surgeries is expected to boost the ASC segment significantly, creating further opportunities for the normal saline market.

Home Care Settings:

The usage of normal saline in home care settings is poised for substantial growth as patients increasingly prefer receiving medical care at home. This shift is influenced by the rising geriatric population and the increased prevalence of chronic diseases that necessitate ongoing IV therapy. Home healthcare providers utilize normal saline to manage hydration, administer medications, and facilitate recovery from various medical conditions. The advantages of home-based care, such as increased comfort and reduced healthcare costs, contribute to the market's expansion. As healthcare regulations evolve to support home healthcare models, the demand for normal saline in this sector is expected to rise considerably.

Others:

The "Others" application segment encompasses a range of healthcare settings, including emergency response units, nursing facilities, and rehabilitation centers where normal saline is utilized in various treatment protocols. In emergency medical services, normal saline is often administered during pre-hospital care to stabilize patients before they reach medical facilities. Rehabilitation centers may also use normal saline in conjunction with other treatments to aid recovery and maintain hydration. While this segment is less prominent in terms of volume compared to hospitals and clinics, it nonetheless represents a critical avenue for the application of normal saline, contributing to the overall market growth.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies are a primary distribution channel for normal saline, ensuring that healthcare facilities have immediate access to essential IV fluids. These pharmacies are responsible for managing inventory, supplying units, and ensuring the availability of saline solutions for various departments within the hospital. The increasing number of surgical procedures and patient admissions necessitates a consistent supply of normal saline, leading to high demand in hospital pharmacies. Furthermore, as hospitals strive to improve operational efficiency, the integration of advanced inventory management systems is facilitating better procurement and utilization of normal saline, thereby reinforcing the significance of this distribution channel.

Retail Pharmacies:

Retail pharmacies serve as an important distribution channel for normal saline, particularly for outpatient treatments and home care needs. Consumers increasingly seek easy access to medical supplies, including saline solutions, for personal use or to aid in home healthcare. Retail pharmacies often work closely with healthcare providers to ensure that patients can obtain the necessary saline prescriptions efficiently. The trend towards self-care and the rise of chronic diseases are driving the demand for over-the-counter saline solutions in retail settings. This segment is expected to grow as retail pharmacies expand their offerings to include a wider array of healthcare products.

Online Pharmacies:

Online pharmacies have emerged as a convenient distribution channel for normal saline, providing consumers with easy access to medical supplies from the comfort of their homes. The growing trend of e-commerce in the healthcare sector is revolutionizing the way patients procure saline solutions, allowing for quick delivery and competitive pricing. Online platforms offer a vast selection of normal saline products, catering to the diverse needs of patients and healthcare providers. Additionally, the COVID-19 pandemic has accelerated the shift towards online purchasing, as individuals look for safe ways to obtain healthcare supplies without visiting physical stores. This segment is expected to witness significant growth in the coming years as digital solutions become an integral part of healthcare delivery.

Drug Stores:

Drug stores represent a traditional distribution channel for normal saline, catering to a wide range of customers seeking medical supplies for personal care. These establishments often stock saline solutions for general use, such as wound care, hydration, and nasal irrigation. The accessibility of drug stores makes them a popular option for consumers, particularly in urban areas where individuals can quickly purchase necessary medical supplies. The demand for normal saline in drug stores is expected to remain steady, driven by increasing awareness of self-care and the necessity for basic healthcare products. Furthermore, drug stores are adapting to meet customer needs by offering consultations and guidance on the proper use of saline solutions, enhancing their role as a healthcare resource.

Others:

The "Others" distribution channel includes independent pharmacies, wholesalers, and specialized medical supply stores that provide normal saline solutions to various healthcare institutions and patients. These channels play a crucial role in ensuring that saline products are accessible to healthcare providers in areas where larger distribution networks may not reach. Independent pharmacies often cater to local communities, offering personalized services and maintaining close relationships with healthcare professionals. The demand through these channels is influenced by regional healthcare needs and the ongoing evolution of patient care delivery. As the healthcare landscape continues to change, the significance of these distribution channels in the normal saline market is expected to persist.

By Ingredient Type

Sodium Chloride:

Sodium chloride is the primary ingredient in normal saline solutions, serving as a critical electrolyte that helps maintain fluid balance in the body. It is essential for various physiological functions, including nerve conduction and muscle contraction. The demand for sodium chloride-based saline is robust, particularly in healthcare settings where its administration is required for hydration, rehydration, and electrolyte replenishment. The versatility of sodium chloride makes it suitable for multiple medical applications, including the management of patients in critical care, surgical procedures, and outpatient treatments. As healthcare providers continue to prioritize patient well-being and effective fluid management, the demand for sodium chloride in normal saline solutions is expected to remain strong.

Water for Injection:

Water for injection is another key ingredient in the formulation of normal saline solutions, playing a vital role in diluting sodium chloride to create isotonic saline. This ingredient must meet stringent quality standards to ensure its safety and sterility for parenteral use. The requirement for pure and contaminant-free water highlights the importance of water quality in the production of normal saline. As healthcare facilities increasingly focus on infection control and patient safety, the demand for high-quality water for injection will continue to rise. The growth of the water for injection segment is expected to reflect the overall expansion of the normal saline market, driven by the increasing emphasis on quality and efficacy in healthcare products.

By Region

The North American market for normal saline for parenteral use is expected to remain the largest due to the advanced healthcare infrastructure, a high prevalence of chronic diseases, and a growing population of elderly individuals. This region is projected to exhibit a CAGR of around 5.5% during the forecast period, fueled by increased utilization of outpatient services and rising surgical procedures. The United States, in particular, dominates the market as a result of the high demand for intravenous therapies and continuous innovations in healthcare technology. Additionally, the presence of major pharmaceutical companies and robust distribution networks significantly contribute to the region's growth in the normal saline market.

In Europe, the normal saline market is also poised for substantial growth, driven by the increasing adoption of home care services and the rise in outpatient treatments. The European region is expected to witness a CAGR of approximately 4.8% during the forecast period. Countries like Germany, France, and the United Kingdom are at the forefront of this growth, bolstered by their advanced healthcare systems and a high standard of patient care. The region's aging population and the increasing incidence of chronic diseases are further propelling the demand for normal saline solutions. Moreover, the integration of technology in healthcare facilities enhances the administration and management of intravenous therapies, thus positively influencing the normal saline market in Europe.

Opportunities

The normal saline for parenteral use market presents numerous opportunities for growth, particularly in developing regions where healthcare infrastructure is rapidly evolving. As more countries prioritize building and expanding their healthcare systems, the demand for essential medical supplies, including normal saline, is expected to surge. With the growing prevalence of chronic diseases and an aging population worldwide, there is a notable increase in the need for intravenous therapies. Companies that invest in establishing distribution networks in these emerging markets will likely benefit from the increasing healthcare expenditures and the focus on improving access to quality medical care. Furthermore, collaborations between pharmaceutical companies and healthcare providers can lead to enhanced product offerings and services, positioning them favorably in the competitive landscape.

Technological advancements in the formulation and delivery of normal saline solutions also present significant opportunities for market players. Innovations such as smart IV systems and portable infusion devices can improve patient outcomes and streamline the administration process. Additionally, the increasing trend towards home healthcare services creates opportunities for companies to develop products tailored for patient use outside of traditional healthcare facilities. By focusing on product development that meets the changing needs of healthcare providers and patients, companies can capture a larger share of the market. Partnerships with telehealth platforms and digital health initiatives can further enhance the reach of normal saline solutions, increasing access to care and improving overall patient satisfaction.

Threats

Despite the growth potential in the normal saline for parenteral use market, several threats could impact its trajectory. One of the primary threats is the rising competition from alternative IV solutions and treatment modalities. As healthcare providers seek to optimize patient care and reduce costs, they may turn to innovative therapies that offer advantages over normal saline, such as electrolyte-rich formulations or more specialized intravenous treatments. This shift could lead to a decrease in the demand for traditional normal saline solutions, posing a challenge for manufacturers to maintain their market share. Furthermore, stringent regulatory requirements in various regions may hinder the introduction of new products to the market, as companies strive to comply with safety and quality standards.

Additionally, fluctuations in the supply chain for raw materials essential for the production of normal saline could pose challenges. Any disruption in the supply of sodium chloride, water for injection, or packaging materials could hinder the manufacturing process and lead to potential shortages in the market. Moreover, increasing concerns regarding environmental sustainability may prompt healthcare providers to reconsider their choices in packaging and product usage, leading to increased scrutiny of plastic materials used in saline solutions. This trend could necessitate the development of more sustainable packaging options, requiring significant investment and innovation from manufacturers to stay competitive.

Competitor Outlook

• Fresenius Kabi AG
• Baxter International Inc.
• Hospira, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• B. Braun Melsungen AG
• McKesson Corporation
• Elekta AB
• Terumo Corporation
• Grifols, S.A.
• Cardinal Health, Inc.
• Vifor Pharma
• Roche Holding AG
• Amgen Inc.
• Sintracare
• Hikma Pharmaceuticals PLC

The competitive landscape of the normal saline for parenteral use market is characterized by a mix of well-established global players and regional manufacturers. Leading companies such as Fresenius Kabi and Baxter International have a significant presence and are known for their extensive product portfolios and robust distribution networks. These companies invest heavily in research and development to innovate new formulations and delivery methods that enhance patient care and safety. Additionally, their strong focus on quality assurance and compliance with regulatory standards positions them favorably in the market. The competitive environment is also influenced by the entry of smaller players offering niche products, which can create potential disruptions in pricing and market strategies.

Fresenius Kabi AG is a notable player in the normal saline market, recognized for its commitment to quality and innovation. The company has a broad range of intravenous solutions, including normal saline, designed to meet the diverse needs of healthcare providers. With a strong global presence and a focus on sustainability, Fresenius Kabi aims to lead in the supply of high-quality parenteral products. Baxter International Inc. is another major competitor, specializing in IV therapies and fluid replacement solutions. The company is known for its advanced technologies in infusion systems, which complement its saline products and enhance patient outcomes. Baxter's continuous commitment to improving healthcare delivery reflects its strong positioning in the market.

B. Braun Melsungen AG stands out with its comprehensive portfolio of intravenous products and commitment to patient safety. The company emphasizes innovation in its packaging and delivery systems, ensuring that its normal saline products meet the highest standards. In addition, B. Braun focuses on enhancing healthcare efficiency through its integrated solutions, establishing strong relationships with healthcare providers. Cardinal Health, Inc. is also a significant player, leveraging its extensive distribution network to provide healthcare providers with timely access to normal saline and other essential medical supplies. The company's focus on supply chain efficiency and customer service enhances its competitive edge in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Elekta AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sintracare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Vifor Pharma
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Grifols, S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Hospira, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Roche Holding AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Fresenius Kabi AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 McKesson Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B. Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Baxter International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hikma Pharmaceuticals PLC
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Otsuka Pharmaceutical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Normal Saline for Parenteral Use Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Home Care Settings
    • 6.1.5 Others
  • 6.2 Normal Saline for Parenteral Use Sales Market, By Product Type
    • 6.2.1 Plastic Bottles
    • 6.2.2 Glass Bottles
    • 6.2.3 IV Bags
    • 6.2.4 IV Bottles
    • 6.2.5 Ampoules
  • 6.3 Normal Saline for Parenteral Use Sales Market, By Ingredient Type
    • 6.3.1 Sodium Chloride
    • 6.3.2 Water for Injection
  • 6.4 Normal Saline for Parenteral Use Sales Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Drug Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Normal Saline for Parenteral Use Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Normal Saline for Parenteral Use Sales market is categorized based on

By Product Type

• Plastic Bottles
• Glass Bottles
• IV Bags
• IV Bottles
• Ampoules

By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Others

By Ingredient Type

• Sodium Chloride
• Water for Injection

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Fresenius Kabi AG
• Baxter International Inc.
• Hospira, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• B. Braun Melsungen AG
• McKesson Corporation
• Elekta AB
• Terumo Corporation
• Grifols, S.A.
• Cardinal Health, Inc.
• Vifor Pharma
• Roche Holding AG
• Amgen Inc.
• Sintracare
• Hikma Pharmaceuticals PLC